|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
Executive Committee: Cornerstone Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Zwinski
CEO | Chief Executive Officer | - | 01/01/2021 |
| Chief Tech/Sci/R&D Officer | 76 | - |
Company details: Cornerstone Therapeutics, Inc.
Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.74% | +0.13% | +15.95% | +62.40% | 46.36B | |
| +3.03% | -3.77% | +32.57% | +102.58% | 36.94B | |
| +2.49% | +0.68% | +9.72% | +75.89% | 11.52B | |
| +1.35% | +0.97% | -11.72% | +11.40% | 11.44B | |
| 0.00% | +0.57% | +19.32% | +148.82% | 9.17B | |
| +1.43% | +1.59% | +29.16% | +38.91% | 7.27B | |
| +2.60% | +1.59% | +37.15% | -18.62% | 7.06B | |
| +0.25% | -0.78% | +16.32% | +182.08% | 7.09B | |
| +1.38% | -4.13% | -42.75% | +6.68% | 4.92B | |
| Average | +1.47% | -1.09% | +11.75% | +67.79% | 15.75B | |
| Weighted average by Cap. | +1.61% | -2.11% | +17.47% | +74.25% |
- Stock Market
- Stocks
- Stock
- Company Cornerstone Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
